Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.86656 | 36 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.80321 | 35 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.8039 | 35 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.67095 | 32 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.74991 | 35 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.92182 | 37 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.80751 | 33 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.77864 | 35 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.77235 | 35 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.79193 | 35 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.78791 | 35 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.77598 | 35 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.79635 | 35 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.78704 | 35 |